12167
clinical study

Impact of an AI-Based Triage and Prioritization Solution for Incidental Pulmonary Embolism Findings on Contrast CT in an Outpatient Setting

Materials & Methods

This study evaluated the impact of an AI-powered system on wait time – defined as the time between study acquisition and when the radiologist began dictation – for patients with suspected incidental pulmonary embolism (iPE) detected during CT scans. Data from a large academic hospital was analyzed from April 2022 to April 2023. The AI system (Aidoc) prioritized cases where iPE was suspected and compared to cases without AI notifications.

Results

During the study period, a total of 28,914 CT exams included the lungs, with 269 suspected positive prioritization notifications (87 chest/abdo/pelvis and 182 chest-only). There was a significant reduction in median wait times for AI-notified cases compared to non-AI-notified cases. Overall, wait times decreased by 64.4%, from 242 minutes to 86 minutes (p<0.001). The reduction was most pronounced for chest/abdo/pelvis scans, with an 83.5% (p<0.001). For chest-only scans, the reduction was 50.6%.

Conclusions

AI-based triage and prioritization can substantially reduce wait times for patients with incidental pulmonary embolism, potentially speeding up diagnosis and treatment.

Explore the Latest AI Insights, Trends and Research

Amalia Schreier

<p>Amalia Schreier serves as the Senior Vice President of Regulatory Affairs and Legal at Aidoc, guiding our company and product’s regulatory strategies and ensuring alignment with AI-focused medical device compliance requirements. Since her tenure began, she has streamlined our FDA clearance processes, emphasizing a meticulous approach that underscores our commitment to product and clinical quality.</p> <p>With a solid foundation from her legal background and leadership role in AI startup regulatory departments, Schreier brings invaluable insights and expertise to our regulatory framework. Prior to her tech world experience, she worked as a human-rights lawyer and legal policy scholar, with a BA and LLM in law from the Hebrew University of Jerusalem.</p>

Deepak Srikant

<p>Deepak Srikant is a global marketing executive with over 20 years of experience, specializing in the commercialization of medical devices and digital health solutions. He has a proven track record in driving growth, having led successful go-to-market strategies, product launches and market expansions across the U.S. and EMEA.</p> <p>Srikant’s expertise extends to upstream and downstream marketing, professional education and sales enablement. His leadership at companies such as Silk Road Medical (acquired by Boston Scientific) and Aptus Endosystems (acquired by Medtronic) has consistently resulted in revenue growth, enhanced customer retention and successful product adoption.</p> <p>Srikant holds an MBA from the Yale School of Management and a bachelor’s degree in mechanical engineering from Rensselaer Polytechnic Institute. Currently, he leads product marketing for Aidoc’s cardiovascular service line.</p>

Laci Costa

<p>Laci Costa is the Director of Neurovascular Product Marketing at Aidoc. She leads marketing and commercial strategy for the neuro AI portfolio of products. She has 16 years of experience working in the medical device and healthcare industry, with over 12 years dedicated to neurovascular solutions.</p> <p>Costa’s known for her expertise in the neurovascular industry, go-to-market experience with new technologies and upstream and downstream product marketing leadership. She’s held various leadership positions in product marketing, clinical education and professional affairs spanning across start-up organizations to large publicly traded companies.</p> <p>Costa holds a bachelor’s degree in psychology from the University of Oklahoma and an MBA from USC Marshall School of Business.</p>